MediciNova, Inc.
MNOV
$1.47
-$0.05-3.29%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -28.91% | -8.20% | 34.38% | 38.17% | 39.08% |
| Total Depreciation and Amortization | 4.43% | 12.57% | 22.91% | 24.14% | 14.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.39% | -36.19% | -54.13% | -41.88% | 25.13% |
| Change in Net Operating Assets | -974.64% | 106.94% | 12.97% | -3,492.06% | -66.48% |
| Cash from Operations | -43.22% | 15.80% | 30.42% | 34.29% | 42.45% |
| Capital Expenditure | 95.77% | 96.58% | 84.75% | -326.00% | -326.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 100.00% | 100.00% | 199.82% |
| Cash from Investing | -100.00% | -100.01% | 96.19% | 71.97% | 199.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -76.88% | -143.29% | -40.87% | 413.89% | 202.98% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -132.74% | -822.76% | 30.90% | 34.70% | 161.40% |